Biotech Startups

耀乘健康科技 (AuroraPrime) is an AI platform for the life sciences and pharmaceutical industry that automates the generation of regulatory and medical documents such as clinical study reports, protocols, and safety narratives across the R&D lifecycle. It also offers Intelligent EDC and medical monitoring tools for pharmaceutical companies, CROs, and research organizations.

2 investors

AusperBio is a Phase II clinical-stage biopharmaceutical company developing oligonucleotide (ASO) therapeutics, with a focus on curative treatments for hepatitis B (HBV). It uses a proprietary Med-Oligo ASO platform and targeted delivery technologies to address viral infections, metabolic, genetic, and immune diseases.

2 investors

Autifony Therapeutics is a privately funded biopharmaceutical company developing treatments for neurological conditions including Fragile X Syndrome and orphan epilepsy syndromes.

2 investors

AutoPhagyGO is a biotech company focused on autophagy research with applications in longevity and age-related disease prevention and treatment. The company leverages cellular regeneration mechanisms to develop therapeutics that promote healthy aging.

2 investors

Avania is a clinical development and regulatory consulting firm that supports medical device companies through product development, clinical trial execution, and FDA regulatory submissions. The company serves medtech innovators navigating complex regulatory pathways from early-stage concept to market clearance.

2 investors

AvantGuard, a Cornell University spin-out originally founded as Halomine, develops N-halamine-based antimicrobial and surface-protection technology aimed at combating pathogens including the fungus Candida (Candidozyma) auris. The company is advancing an antifungal decolonization protocol toward FDA approval, targeting fungal skin and nail infections and healthcare antiseptic applications.

2 investors

Avelo develops diagnostic technology aimed at closing the diagnostic gap in respiratory disease, so patients receive timely and accurate information for effective treatment. The company operates in the medical diagnostics field with an emphasis on technology and science.

2 investors

Avery Therapeutics is a biotechnology company focused on developing immunomodulatory biologic therapeutics. It is led by an executive team and supported by a board of directors and a scientific and medical advisory board.

2 investors

Avionova develops bioastronautics research and technology commercialization solutions, serving the aerospace and medical sectors with expertise in dual-use product strategy and commercialization.

2 investors

Repligen provides bioprocessing technologies—including process intensification, tangential flow filtration, chromatography, process analytics, and single-use fluid management—for upstream and downstream biopharmaceutical workflows. It serves biopharma and CDMO teams developing and manufacturing modalities such as monoclonal antibodies, ADCs, mRNA, and cell and gene therapies.

2 investors

Zimmer Biomet's Avitus Bone & Marrow Harvester is a minimally invasive suction curettage device designed for orthopedic surgeons to harvest cancellous bone and bone marrow, and to debride infected or diseased bone through small incisions at accessible sites like the tibia and calcaneus. The sterile-packed, disposable system enables percutaneous autologous bone and marrow harvesting for surgical grafting procedures.

2 investors

Axelia Oncology is a biopharmaceutical company developing AXA-042, a selective immunological agent designed to activate innate immune responses against checkpoint-insensitive solid tumors. The company focuses on oncology therapeutics through activation of TLR2/6 pathways.

2 investors

Axogen develops and commercializes technologies for peripheral nerve regeneration and repair, offering clinically proven surgical solutions to restore feeling and function to damaged nerves. Its products serve surgeons and healthcare providers treating patients with peripheral nerve damage.

2 investors

Axovia Therapeutics develops AAV9-based gene therapies for ciliopathies, a group of rare inherited genetic diseases, with a lead program targeting Bardet-Biedl Syndrome (BBS1) to prevent blindness and reverse obesity. A spin-off from University College London, its second program targets the most common genetic cause of obesity.

2 investors

Ayala Pharma is associated with pharmaceutical drug candidates including AL102, AL101, and BST-236; the page states that AL102 and AL101 were acquired by Immunome, Inc. in Q1 2024.

2 investors

Azadyne is a UK biotech company and spin-out from Trinity College Dublin developing therapeutics based on tRNA modification and epigenetic regulation of cellular protein synthesis. Its work targets the treatment of disease through this novel mechanism.

2 investors

Azalea Therapeutics develops precision genome editing therapies that engineer T cells directly inside the patient's body to create cancer immunotherapies, using proprietary delivery vehicles to target and modify specific genetic loci without ex vivo cell manipulation.

2 investors

AZBio is a statewide industry association and advocate for Arizona's bioscience sector, connecting biotech, medtech, and healthcare organizations to support the state's life science ecosystem. The organization provides resources, leadership, and advocacy to establish Arizona as a top-ten life science state.

2 investors

Clinical-stage biopharmaceutical company developing best-in-class aryl hydrocarbon receptor agonists.

2 investors

Clinical biopharmaceutical company developing treatments for neurological conditions.

2 investors

Azulene Labs develops physics-powered molecular discovery technology. The company serves scientists and engineers working in molecular research and discovery.

2 investors

Bacta develops an AI-powered bioproduction platform that uses microorganisms to produce industrial ingredients, starting with astaxanthin. Its ingredients are offered in multiple forms with traceability for the cosmetics, human nutrition, and animal nutrition markets.

2 investors

Bactolife develops Binding Proteins for use in functional foods for humans and in animal feed, aimed at supporting healthy digestion and livestock health. It positions its products as affordable, science-based solutions sold to food producers and the animal feed industry.

2 investors

BAMF Health describes itself as a global team working in healthcare. The page provides no concrete detail about the company's products or services.

2 investors